The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Tempus AI leverages AI for treatment decisions and diagnostics, thriving in the booming healthcare AI market with strong ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 AC Immune to host symposium ...

Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, today announced the expansion of its US patent portfolio. Strengthening its cardiometabolic treatment portfolio, the Company now ...

Disease is not one-size-fits-all, as anyone who has had the common cold can attest. Bodies, environments, and lived ...

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

VAEs also introduce mathematical constraints that accommodate computational models called large neural networks. To continue with the example of large language models, these neural networks can be ...

Lifespan is outpacing the number of years people live in good health. Scientists are developing ways of preventing illness and slowing the aging process ...

Proscia® has raised $50 million in its latest funding round, bringing its total funding to $130 million. This investment, led by Insight Partners, follows a year of record-breaking ...